APA (7th ed.) Citation

Santarpia, M., Altavilla, G., Pitini, V., & Rosell, R. (2015). Personalized treatment of early-stage non-small-cell lung cancer: The challenging role of EGFR inhibitors. Future oncology (London, England), 11(8), 1259-1274. https://doi.org/10.2217/fon.14.320

Chicago Style (17th ed.) Citation

Santarpia, Mariacarmela, Giuseppe Altavilla, Vincenzo Pitini, and Rafael Rosell. "Personalized Treatment of Early-stage Non-small-cell Lung Cancer: The Challenging Role of EGFR Inhibitors." Future Oncology (London, England) 11, no. 8 (2015): 1259-1274. https://doi.org/10.2217/fon.14.320.

MLA (9th ed.) Citation

Santarpia, Mariacarmela, et al. "Personalized Treatment of Early-stage Non-small-cell Lung Cancer: The Challenging Role of EGFR Inhibitors." Future Oncology (London, England), vol. 11, no. 8, 2015, pp. 1259-1274, https://doi.org/10.2217/fon.14.320.